Axon Therapies Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $32M

  • Investors
  • 7

Axon Therapies General Information

Description

Developer of a healthcare device designed to reduce sympathetic nerve activity and address the root cause of heart failure. The company's device allows clinicians to ablate the right greater splanchnic nerve using a small catheter inserted through the groin and helps to normalize sympathetic nervous activity, to shift blood volume from the heart back to the splanchnic bed, reducing pressures in the heart, enabling clinicians to begin treatment quickly, resulting in a high likelihood of successful treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 345 Park Avenue South
  • New York, NY 10010
  • United States
+1 (212)
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 345 Park Avenue South
  • New York, NY 10010
  • United States
+1 (212)

Axon Therapies Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Axon Therapies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series A) 25-Sep-2025 $32M Completed Generating Revenue
6. Debt - General 25-Apr-2023 Completed Clinical Trials - General
5. Later Stage VC (Series A) 28-Jan-2021 Completed Clinical Trials - General
4. Later Stage VC (Series A) 07-Feb-2019 Completed Clinical Trials - General
3. Early Stage VC (Series AA) 26-Jun-2017 Completed Clinical Trials - General
2. Early Stage VC (Series AA) 19-Apr-2016 $2M $2M Completed Clinical Trials - General
1. Accelerator/Incubator Completed Startup
To view Axon Therapies’s complete valuation and funding history, request access »

Axon Therapies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A V
Series A NV
Series AA NV 1,833,334 $0.001000 $0.11 $1.8 $1.8 1x $1.8 15.44%
Series AA V 1,650,000 $0.001000 $0.12 $2 $2 1x $2 0%
To view Axon Therapies’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Axon Therapies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a healthcare device designed to reduce sympathetic nerve activity and address the root cause of heart failu
Surgical Devices
New York, NY
20 As of 2024

Mansfield, MA
 

Irvine, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Axon Therapies Competitors (17)

One of Axon Therapies’s 17 competitors is BioVentrix, a Venture Capital-Backed company based in Mansfield, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioVentrix Venture Capital-Backed Mansfield, MA
ClearFlow Venture Capital-Backed Irvine, CA
Magnolia Medical Technologies Private Equity-Backed Seattle, WA
HighLife Venture Capital-Backed Paris, France
Biotronik Corporate Backed or Acquired Berlin, Germany
You’re viewing 5 of 17 competitors. Get the full list »

Axon Therapies Patents

Axon Therapies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026076344-A1 A method of treating a patient having heart failure and a method of selecting a patient for a splanchnic ablation procedure Pending 04-Oct-2024
US-12390220-B2 Surgical stapler cartridge having raised surface to promote buttress adhesion Active 19-May-2023
US-20240382202-A1 Surgical stapler cartridge having raised surface to promote buttress adhesion Active 19-May-2023
JP-2024520745-A Method, device and system for treating a patient with gsn ablation Pending 07-Jun-2021
AU-2022290510-A1 Methods, devices and systems for treating a patient by gsn ablation Pending 07-Jun-2021 A61B18/1492
To view Axon Therapies’s complete patent history, request access »

Axon Therapies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Axon Therapies Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
CDBI Partners Venture Capital Minority
Earlybird Venture Capital Venture Capital Minority
KOFA Healthcare Venture Capital Minority
Santé Ventures Venture Capital Minority
Deerfield Management Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Axon Therapies FAQs

  • When was Axon Therapies founded?

    Axon Therapies was founded in 2014.

  • Where is Axon Therapies headquartered?

    Axon Therapies is headquartered in New York, NY.

  • What is the size of Axon Therapies?

    Axon Therapies has 20 total employees.

  • What industry is Axon Therapies in?

    Axon Therapies’s primary industry is Surgical Devices.

  • Is Axon Therapies a private or public company?

    Axon Therapies is a Private company.

  • What is Axon Therapies’s current revenue?

    The current revenue for Axon Therapies is .

  • How much funding has Axon Therapies raised over time?

    Axon Therapies has raised $75.8M.

  • Who are Axon Therapies’s investors?

    CDBI Partners, Earlybird Venture Capital, KOFA Healthcare, Santé Ventures, and Deerfield Management are 5 of 7 investors who have invested in Axon Therapies.

  • Who are Axon Therapies’s competitors?

    BioVentrix, ClearFlow, Magnolia Medical Technologies, HighLife, and Biotronik are some of the 17 competitors of Axon Therapies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process